Konar Monica, Rossi Raffaella, Walter Helen, Pajon Rolando, Beernink Peter T
Center for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute, UCSF Benioff Children's Hospital Oakland, Oakland, CA, United States of America.
Center for Immunobiology and Vaccine Development, Children's Hospital Oakland Research Institute, UCSF Benioff Children's Hospital Oakland, Oakland, CA, United States of America; Biology Department, Mills College, Oakland, CA, United States of America.
PLoS One. 2015 Jun 9;10(6):e0128185. doi: 10.1371/journal.pone.0128185. eCollection 2015.
Factor H binding protein (FHbp) is a virulence factor used by meningococci to evade the host complement system. FHbp elicits bactericidal antibodies in humans and is part of two recently licensed vaccines. Using human complement Factor H (FH) transgenic mice, we previously showed that binding of FH decreased the protective antibody responses to FHbp vaccination. Therefore, in the present study we devised a library-based method to identify mutant FHbp antigens with very low binding of FH. Using an FHbp sequence variant in one of the two licensed vaccines, we displayed an error-prone PCR mutant FHbp library on the surface of Escherichia coli. We used fluorescence-activated cell sorting to isolate FHbp mutants with very low binding of human FH and preserved binding of control anti-FHbp monoclonal antibodies. We sequenced the gene encoding FHbp from selected clones and introduced the mutations into a soluble FHbp construct. Using this approach, we identified several new mutant FHbp vaccine antigens that had very low binding of FH as measured by ELISA and surface plasmon resonance. The new mutant FHbp antigens elicited protective antibody responses in human FH transgenic mice that were up to 20-fold higher than those elicited by the wild-type FHbp antigen. This approach offers the potential to discover mutant antigens that might not be predictable even with protein structural information and potentially can be applied to other microbial vaccine antigens that bind host proteins.
补体因子H结合蛋白(FHbp)是脑膜炎球菌用来逃避宿主补体系统的一种毒力因子。FHbp可在人体内引发杀菌性抗体,并且是两种最近获批疫苗的组成部分。我们之前利用人补体因子H(FH)转基因小鼠证明,FH的结合会降低对FHbp疫苗接种的保护性抗体反应。因此,在本研究中,我们设计了一种基于文库的方法,以鉴定与FH结合能力极低的突变型FHbp抗原。利用两种获批疫苗之一中的一种FHbp序列变体,我们在大肠杆菌表面展示了一个易错PCR突变型FHbp文库。我们使用荧光激活细胞分选技术分离出与人FH结合能力极低且保留与对照抗FHbp单克隆抗体结合能力的FHbp突变体。我们对选定克隆中编码FHbp的基因进行了测序,并将这些突变引入可溶性FHbp构建体中。通过这种方法,我们鉴定出了几种新的突变型FHbp疫苗抗原,通过酶联免疫吸附测定和表面等离子体共振测量,它们与FH的结合能力极低。这些新的突变型FHbp抗原在人FH转基因小鼠中引发的保护性抗体反应比野生型FHbp抗原引发的反应高20倍。这种方法有可能发现即使有蛋白质结构信息也可能无法预测的突变抗原,并且有可能应用于其他与宿主蛋白结合的微生物疫苗抗原。